# Rein Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Rein Therapeutics, Inc.](/companies/rntx.md) (CIK 1420565)
- Form: 10-K/A
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 06:51 ET
- Period: 2025-12-31
- Accession: 0001193125-26-178787
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526178787/rntx-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420565/000119312526178787/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1420565/000119312526178787/rntx-20251231.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-178787. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.